HHealthcare Read More Eli Lilly on track to launch oral obesity drug in second quarter, pending US approvalMarch 5, 2026 March 2 (Reuters) – Eli Lilly CFO ‌Lucas Montarce said ‌on Monday it is ​preparing to launch its…
HHealthcare Read More Denver company’s AI could flag premature births based on ultrasoundsMarch 5, 2026 A Denver company has received federal approval to market an artificial intelligence program it says can predict when…
TTV Read More Broadcast Journalist and Author Joan Lunden to Discuss Her Memoir and Career at National Press Club, Mar. 19March 4, 2026 WASHINGTON, March 4, 2026 /PRNewswire/ — Journalist and former Good Morning America host Joan Lunden will discuss her memoir,…
HHealth Read More Explainer | How TCM’s ‘miracle pill’ is used to treat strokes, but experts urge cautionMarch 1, 2026 This series is based on our reporting on TCM: its history, treatments and growing acceptance around the world.…
MMedication Read More FDA to offer bonus payments to staffers who complete speedy drug reviewsMarch 1, 2026 WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to…
MMedication Read More FDA will drop two-study requirement for new drug approvals, aiming to speed accessFebruary 19, 2026 WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
MMedication Read More FDA will drop two-study requirement for new drug approvals, aiming to speed accessFebruary 19, 2026 WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
MMedication Read More FDA accepts BMS protein degrader for review; Disc rare disease drug rejectedFebruary 19, 2026 This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
MMedication Read More Disc Medicine to pursue traditional U.S. approval after FDA rejects new fast-track routeFebruary 17, 2026 Feb 17 (Reuters) – Disc Medicine said ‌on Tuesday it ‌will pursue a traditional ​U.S. approval pathway for…
MMedication Read More Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up studyFebruary 12, 2026 This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
MMedication Read More Over-the-counter ivermectin sales proposed in GeorgiaJanuary 31, 2026 ATLANTA, Ga. (Atlanta News First) — A Georgia state lawmaker wants to allow over-the-counter sales of a drug…
HHealthcare Read More Let’s Be Honest About Public Health Guidance – Emily OsterJanuary 29, 2026 In the first week of January, the Health and Human Services Department, under Secretary Robert F. Kennedy Jr.,…